Market Cap 82.96M
Revenue (ttm) 0.00
Net Income (ttm) -210.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 408,900
Avg Vol 836,590
Day's Range N/A - N/A
Shares Out 61.45M
Stochastic %K 38%
Beta 1.32
Analysts Hold
Price Target $2.50

Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonal...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 481 6770
Address:
331 Oyster Point Boulevard, South San Francisco, United States
THSSKS
THSSKS Mar. 16 at 6:00 PM
$PLRX I can’t see the reports from Piper and Cannacord, but analysts must think the pipeline is worth absolute dog shit if they’re giving this a $3 pt which is near liquidation prices. Someone is relentlessly selling blocks the last couple of days too, definitely a fund that wants out. I was in this for a buyout which isn’t happening now, so good luck to everyone. I’m not letting this turn into another KZR who is still doing nothing after 2 years of poison pills to stop Tang, they had way more cash to market cap than plrx too 2 years ago. Management is screwing shareholders here pursuing new pipeline instead of finding alternatives. ✌️
2 · Reply
Stockboi_
Stockboi_ Mar. 13 at 5:47 PM
$PLRX need to hold support and we see higher. Strong daily chart
0 · Reply
NorthStarStats
NorthStarStats Mar. 13 at 11:57 AM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $APD Score: 100, $MOS Score: 95, $PLRX Score 71, $SBUX Score 70, $AWK Score 70
0 · Reply
anachartanalyst
anachartanalyst Mar. 12 at 5:02 PM
$PLRX https://anachart.com/wp-content/uploads/ana_temp/1773334907_soc-img.jpg
0 · Reply
sandman7473
sandman7473 Mar. 12 at 2:13 PM
$PLRX inverse head and shoulders setting up.
0 · Reply
THSSKS
THSSKS Mar. 12 at 3:45 AM
$PLRX overall data is encouraging but only 10 patients. This might need bigger phase 2 data to pop, hopefully I’m wrong but I don’t think so. roughly 2m patients worldwide receive checkpoint inhibitors. ~$100,000 per person implies a multi billion TAM. Board needs to buy stock
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 12 at 1:00 AM
$PLRX Q4 '25 Earnings Results & Recap Pliant Therapeutics expects research and development expenses and general and administrative expenses to decrease in 2026 due to reprioritization and restructuring, with existing capital sufficient for the next 12 months and beyond.
0 · Reply
focafoca99
focafoca99 Mar. 11 at 10:33 PM
$PLRX said Phase 1 data showed deep and durable responses in checkpoint-inhibitor-refractory solid tumors
0 · Reply
sandman7473
sandman7473 Mar. 11 at 8:30 PM
$PLRX positive data.
0 · Reply
islandpunk
islandpunk Mar. 11 at 8:07 PM
$PLRX https://www.stocktitan.net/news/PLRX/pliant-therapeutics-provides-corporate-update-and-reports-fourth-9po7v43kkgxz.html
0 · Reply
Latest News on PLRX
Pliant Therapeutics Provides Update on BEACON-IPF

Jun 27, 2025, 4:05 PM EDT - 9 months ago

Pliant Therapeutics Provides Update on BEACON-IPF


Pliant Therapeutics: An Activist On Deck

Apr 3, 2025, 12:22 PM EDT - 1 year ago

Pliant Therapeutics: An Activist On Deck


THSSKS
THSSKS Mar. 16 at 6:00 PM
$PLRX I can’t see the reports from Piper and Cannacord, but analysts must think the pipeline is worth absolute dog shit if they’re giving this a $3 pt which is near liquidation prices. Someone is relentlessly selling blocks the last couple of days too, definitely a fund that wants out. I was in this for a buyout which isn’t happening now, so good luck to everyone. I’m not letting this turn into another KZR who is still doing nothing after 2 years of poison pills to stop Tang, they had way more cash to market cap than plrx too 2 years ago. Management is screwing shareholders here pursuing new pipeline instead of finding alternatives. ✌️
2 · Reply
Stockboi_
Stockboi_ Mar. 13 at 5:47 PM
$PLRX need to hold support and we see higher. Strong daily chart
0 · Reply
NorthStarStats
NorthStarStats Mar. 13 at 11:57 AM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $APD Score: 100, $MOS Score: 95, $PLRX Score 71, $SBUX Score 70, $AWK Score 70
0 · Reply
anachartanalyst
anachartanalyst Mar. 12 at 5:02 PM
$PLRX https://anachart.com/wp-content/uploads/ana_temp/1773334907_soc-img.jpg
0 · Reply
sandman7473
sandman7473 Mar. 12 at 2:13 PM
$PLRX inverse head and shoulders setting up.
0 · Reply
THSSKS
THSSKS Mar. 12 at 3:45 AM
$PLRX overall data is encouraging but only 10 patients. This might need bigger phase 2 data to pop, hopefully I’m wrong but I don’t think so. roughly 2m patients worldwide receive checkpoint inhibitors. ~$100,000 per person implies a multi billion TAM. Board needs to buy stock
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 12 at 1:00 AM
$PLRX Q4 '25 Earnings Results & Recap Pliant Therapeutics expects research and development expenses and general and administrative expenses to decrease in 2026 due to reprioritization and restructuring, with existing capital sufficient for the next 12 months and beyond.
0 · Reply
focafoca99
focafoca99 Mar. 11 at 10:33 PM
$PLRX said Phase 1 data showed deep and durable responses in checkpoint-inhibitor-refractory solid tumors
0 · Reply
sandman7473
sandman7473 Mar. 11 at 8:30 PM
$PLRX positive data.
0 · Reply
islandpunk
islandpunk Mar. 11 at 8:07 PM
$PLRX https://www.stocktitan.net/news/PLRX/pliant-therapeutics-provides-corporate-update-and-reports-fourth-9po7v43kkgxz.html
0 · Reply
StockNews_Live
StockNews_Live Mar. 11 at 8:06 PM
$PLRX 🎯 STOCK NEWS ALERT 💵 Price: $1.35 (-2.52%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Pliant Therapeutics, Inc. provided a corporate update and reported fourth quarter 2025 financial results. The company announced positive data from its lead oncology program in ICI-refractory… 📎 https://stocknews.live/news/PLRX/pliant-therapeutics-provides-corporate-90616.html
0 · Reply
StockNews_Live
StockNews_Live Mar. 11 at 8:05 PM
$PLRX 🎯 STOCK NEWS ALERT 💵 Price: $1.34 (-3.24%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Pliant Therapeutics, Inc. provided a corporate update and reported fourth quarter 2025 financial results. The company's lead oncology program, PLN-101095, showed deep and durable ongoing responses in… 📎 https://stocknews.live/news/PLRX/pliant-therapeutics-provides-corporate-33623.html
0 · Reply
Lyn30
Lyn30 Mar. 11 at 12:38 PM
$PLRX Nice
0 · Reply
SurdifiedStocks
SurdifiedStocks Mar. 10 at 6:22 PM
$PLRX That was likely the top folks.
0 · Reply
JacobJones1
JacobJones1 Mar. 10 at 5:31 PM
$PLRX gonna keep climbing. Just getting started.
0 · Reply
Creyedr
Creyedr Mar. 10 at 2:31 PM
$PLRX let's go
0 · Reply
sandman7473
sandman7473 Mar. 10 at 1:55 PM
$PLRX 👀
1 · Reply
sandman7473
sandman7473 Mar. 9 at 2:10 PM
$PLRX reports today after hours I believe.
1 · Reply
Lyn30
Lyn30 Mar. 7 at 10:39 PM
$PLRX Hope it’s finally started , many back and forth
0 · Reply
dtankersley
dtankersley Mar. 6 at 7:52 PM
$PLRX LFG!
0 · Reply
THSSKS
THSSKS Mar. 5 at 9:41 AM
$PLRX these loser insiders are desperately trying to stop a sale of the company yet they never buy any shares either. If they believe in the pipeline so much, they should be buying shares at all time lows or just liquidating the company for a few dollars per share. They better start pumping this up and getting me to at least 400% profits somehow
1 · Reply
sandman7473
sandman7473 Mar. 4 at 2:21 PM
$PLRX https://www.tipranks.com/news/company-announcements/pliant-therapeutics-extends-stockholder-rights-agreement-expiration They extended the “poison pill” for another year. Interesting? 🧐
2 · Reply